RAVASIO, R.; ANTONELLI, S.; ROGAI, V.; FAKHOURI, W.; CAPRON, J. P.; LOSI, S. Mean cost per number needed to treat of baricitinib versus adalimumab in the treatment of rheumatoid arthritis in Italy. Global and Regional Health Technology Assessment, [S. l.], v. 5, n. 1, 2018. DOI: 10.33393/grhta.2018.435. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/435. Acesso em: 22 nov. 2024.